Tauromustine

DB19978ExperimentalSmall molecule

Tauromustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Tauromustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative. Tauromustine has a... Tauromustine has a monoisotopic molecular weight of 286.05 Da.

Formula / weight: C₇H₁₅ClN₄O₄S · 286.73 g/mol (avg)

Resolves to

Compound

UNII511F69K76YCAS85977-49-7ChEMBLCHEMBL2104789

Structure

InChIKeyRCLLNBVPCJDIPX-UHFFFAOYSA-NSMILESCN(C)S(=O)(=O)CCNC(=O)N(CCCl)N=O

Targets

Q746J6Cytochrome P450

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tauromustine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account